AEterna Zentaris to Present at Upcoming William Blair & Company Small-Cap Growth Stock Conference in New York and BioContact in
September 26 2007 - 7:30AM
PR Newswire (US)
QUEBEC CITY, Sept. 26 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company
focused on endocrine therapy and oncology, today announced that its
President and Chief Executive Officer, David J. Mazzo, Ph.D., will
present a Company overview at the William Blair & Company
Small-Cap Growth Stock Conference on Wednesday, October 3, 2007, at
10:40 am Eastern, in Room 6 of the New York Palace Hotel in New
York City. A live webcast of this presentation will be available on
AEterna Zentaris' website at http://www.aeternazentaris.com/ in the
Investors section. A replay will also be available for a period of
90 days on the Company's website. On the following day, Thursday,
October 4, Dr. Mazzo will also present a Company overview at
BioContact at 9:30 am Eastern in the Place d'Armes Room of the
Fairmont Le Chateau Frontenac Hotel in Quebec City, Canada. About
AEterna Zentaris Inc. AEterna Zentaris Inc. is global
biopharmaceutical company focused on endocrine therapy and oncology
with proven expertise in drug discovery, development and
commercialization. News releases and additional information are
available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA
ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475, ; Paul
Burroughs, Media Relations, (418) 652-8525 ext. 406,
Copyright